🇸🇦 Novo Genomics Takes the Global Stage at

We’re proud to announce that Novo Genomics is participating this week in two major milestones at the BIO International Convention 2025 in Boston, showcasing Saudi Arabia’s growing leadership in biotechnology and precision medicine.

🔹 1. Startup Stadium Finalist – June 17, 2025
Novo Genomics has been selected as the only Saudi biotech company to reach the finalist stage of the Startup Stadium, alongside 50+ top startups globally. We will be pitching innovations in genomics and personalized medicine that address unique MENA clinical needs.

🔹 2. Saudi MOH Biotech Accelerator Launch – June 19, 2025
We’re honored to be among the selected startups in the Saudi Ministry of Health Biotech Accelerator, led by RedBiotech. This 7-month program is a major step toward scaling locally driven R&D in areas like PRS, Gut Microbiome, and Precision Oncology.

🎙️ Representing Novo Genomics at both key events is our Co-founder and CEO, Dr. Abdulelah Alhawsawi, who continues to champion Saudi innovation on global platforms.

These recognitions reflect our deep commitment to localizing genomics and creating scalable health solutions aligned with Vision 2030.